Recent advances in the pharmacotherapy of epilepsy
Open Access
- 1 May 1997
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 19 (3) , 369-382
- https://doi.org/10.1016/s0149-2918(97)80124-5
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx®) versus intravenous phenytoin (Dilantin®) in hospital emergency departmentsClinical Therapeutics, 1996
- Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial EpilepsyEpilepsia, 1996
- Drug Interaction Profile of TopiramateEpilepsia, 1996
- Lamotrigine for the treatment of epilepsy in childhoodThe Journal of Pediatrics, 1995
- Lack of Interaction of Gabapentin with Carbamazepine or ValproateEpilepsia, 1994
- Interaction of lamotrigine with sodium valproateThe Lancet, 1993
- Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studiesEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Lamotrigine in primary generalised epilepsyThe Lancet, 1992
- Diurnal Fluctuations in Free and Total Steady‐State Plasma Levels of Carbamazepine and Correlation with Intermittent Side EffectsEpilepsia, 1984
- Correlation Between Daily Fluctuations of Carbamazepine Serum Levels and Intermittent Side EffectsEpilepsia, 1980